Cite
MLA Citation
Kåre I. Birkeland et al.. “How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study.” Diabetes, obesity & metabolism, vol. 21, no. 4, 2019, pp. 968–974. http://access.bl.uk/ark:/81055/vdc_100078583861.0x000017